Andrew Breithaupt, MD
MOHS-Micrographic Surgery · Los Angeles, CANPI 1437460359
Payments from drug & device makers
Across 219 payments — averaging $49.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$3K
- Sanofi$3K
- AbbVie$1K
- Biofrontera Inc.$568
- Incyte Corporation$363
- Johnson & Johnson$342
- plus $2K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $3,497 |
| Sanofi | 7 | $2,934 |
| AbbVie | 65 | $1,116 |
| Biofrontera Inc. | 7 | $568 |
| Incyte Corporation | 16 | $363 |
| Johnson & Johnson | 18 | $342 |
| Sun Pharmaceutical Industries Inc. | 11 | $217 |
| Novartis | 10 | $215 |
| E.r. Squibb & Sons, L.L.C. | 7 | $197 |
| LEO Pharma Inc. | 7 | $148 |
| Almirall LLC | 6 | $119 |
| UCB, Inc. | 5 | $116 |
| Organogenesis Inc. | 5 | $109 |
| Fresenius Kabi USA, LLC | 3 | $75 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $67 |
| Glenmark Therapeutics Inc. | 1 | $60 |
| Amgen | 2 | $58 |
| Lilly USA, LLC | 3 | $53 |
| Verrica Pharmaceuticals Inc. | 2 | $48 |
| Bristol Myers Squibb | 2 | $47 |
| Smith+Nephew | 1 | $47 |
| Sandoz | 2 | $46 |
| Genentech USA, Inc. | 2 | $43 |
| VYNE Pharmaceuticals Inc. | 2 | $36 |
| Krystal Biotech Inc | 1 | $32 |
| Surgenex LLC | 1 | $24 |
| Prugen, Inc. Pharmaceuticals | 2 | $23 |
| Blueprint Medicines Corporation | 1 | $23 |
| DUSA Pharmaceuticals, Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Aclaris Therapeutics, Inc. | 1 | $19 |
| Pfizer | 1 | $19 |
| EPI Health, LLC | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $14 |
How this compares
$10,757 in reported general payments places this provider in the 85th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other mohs-micrographic surgery in Los Angeles
- Lance ChapmanLos Angeles$11K
- Michael MortazieOrange$1.2M
- Thuzar ShinSacramento$353K
- Sarah ArronBurlingame$223K
- Christopher Crosbyla Mesa$211K
- Abel TorresLoma Linda$136K
- Robert ScheinbergOceanside$129K
- Sherry RotundaOceanside$99K
- Sumaira AasiStanford$66K
- Daniel Zelacla Jolla$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.